Skip to main content
Top
Published in: Clinical Rheumatology 1/2004

01-02-2004 | Original Article

The significance of altered gelatinase expression in the synovium of patient with arthritic effusions

Authors: Ko-Hsiu Lu, Shun-Fa Yang, Shu-Chen Chu, Pei-Ni Chen, Ming-Chih Chou, Tang-Yan Hsiao, Yih-Shou Hsieh

Published in: Clinical Rheumatology | Issue 1/2004

Login to get access

Abstract

In this study we quantified the levels of matrix metalloproteinase-2 and 9 (MMP-2 and 9) in effusions and serial synovial cultures of patients with arthritis of the knee in order to investigate the correlations between MMP and cell counts in effusions as well as the possible roles of the synovium. In 49 patients with arthritis of the knee (series I) we examined the cell counts and the amounts of MMP-2 and 9 in 51 effusions. In 20 knee samples of series I of patients who received arthroscopy (series II), we examined the amounts of MMP-2 and 9 in effusions and serial synovial organ cultures. We also compared the gene expressions of MMP-2 and 9 and MT1-MMP in serial synovial cultures using RT-PCR. In series I, significantly more proMMP-9 appeared in effusions from the inflammatory group than in the non-inflammatory and hemorrhagic group (p <0.001). The levels of proMMP-9 correlated with the neutrophil counts in the effusions (p <0.001). In series II synovial cultures, the activities of latent and activated forms of MMP-2 and 9 in lesional areas were all higher than that in paralesional ones (p <0.05). In RT-PCR analysis, MMP-2, -9 and membrane type 1 MMP mRNA levels of lesional areas also showed increased expression. Our data suggest that the analysis of MMP-9 indicates the inflammatory condition of the joints and that additional synovectomy may be beneficial for patients with inflammatory synovitis, compared with non-inflammatory and hemorrhagic arthritis.
Literature
1.
go back to reference Murphy G, Knauper V, Cowell S, Hembry RM (1999) Matrix turnover in joint tissues: the role of metalloproteinases. In: Archer CW, Caterson B, Benjamin M, Ralphs JR (eds) Biology of the synovial joint. Harwood Academic Publishers, Newark, NJ, pp 177–186 Murphy G, Knauper V, Cowell S, Hembry RM (1999) Matrix turnover in joint tissues: the role of metalloproteinases. In: Archer CW, Caterson B, Benjamin M, Ralphs JR (eds) Biology of the synovial joint. Harwood Academic Publishers, Newark, NJ, pp 177–186
2.
go back to reference Hembry RM, Dyce J, Driesang I et al. (2001) Immunolocalization of matrix metalloproteinases in partial-thickness defects in pig articular cartilage. A preliminary report. J Bone Joint Surg Am 83:826–838 Hembry RM, Dyce J, Driesang I et al. (2001) Immunolocalization of matrix metalloproteinases in partial-thickness defects in pig articular cartilage. A preliminary report. J Bone Joint Surg Am 83:826–838
3.
go back to reference Woessner JF (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145–2154PubMed Woessner JF (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145–2154PubMed
4.
go back to reference Matrisian LM (1992) The matrix-degrading metalloproteinases. Bioessays 14:455–463PubMed Matrisian LM (1992) The matrix-degrading metalloproteinases. Bioessays 14:455–463PubMed
5.
go back to reference Murphy G, Docherty AJP (1992) The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol 7:120–125PubMed Murphy G, Docherty AJP (1992) The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol 7:120–125PubMed
6.
go back to reference Opdenakker G, Masure S, Grillet B, Van Damme J (1991) Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis. Lymphokine Cytokine Res 10:317–324PubMed Opdenakker G, Masure S, Grillet B, Van Damme J (1991) Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis. Lymphokine Cytokine Res 10:317–324PubMed
7.
go back to reference Hirose T, Reife RA, Smith GN, Stevens RM, Mainardi CL, Hasty KA (1992) Characterization of type V collagenase (gelatinase) in synovial fluid of patients with inflammatory arthritis. J Rheumatol 19:593–599PubMed Hirose T, Reife RA, Smith GN, Stevens RM, Mainardi CL, Hasty KA (1992) Characterization of type V collagenase (gelatinase) in synovial fluid of patients with inflammatory arthritis. J Rheumatol 19:593–599PubMed
8.
go back to reference Omura K, Takahashi M, Omura T et al. (2002) Changes in the concentration of plasma matrix metalloproteinases (MMP) and tissue inhibitor of metalloproteinases-1 (TIMP-1) after total joint replacement in patients with arthritis. Clin Rheumatol 21:488–492PubMed Omura K, Takahashi M, Omura T et al. (2002) Changes in the concentration of plasma matrix metalloproteinases (MMP) and tissue inhibitor of metalloproteinases-1 (TIMP-1) after total joint replacement in patients with arthritis. Clin Rheumatol 21:488–492PubMed
9.
go back to reference Koolwijk P, Miltenburg AMM, van Erck MGM et al. (1995) Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation. J Rheumatol 22:385–393PubMed Koolwijk P, Miltenburg AMM, van Erck MGM et al. (1995) Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation. J Rheumatol 22:385–393PubMed
10.
go back to reference Van den Steen PE, Proost P, Grillet B et al. (2002) Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis. FASEB J 16:379–389CrossRefPubMed Van den Steen PE, Proost P, Grillet B et al. (2002) Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis. FASEB J 16:379–389CrossRefPubMed
11.
go back to reference Arnett FC, Edworthy SM, Bloch DA et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMed Arnett FC, Edworthy SM, Bloch DA et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMed
12.
go back to reference Altman R, Asch E, Bloch D et al. (1986) Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 29:1039–1049PubMed Altman R, Asch E, Bloch D et al. (1986) Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 29:1039–1049PubMed
13.
go back to reference Lu KH, Hsiao YM, Lin ZI (1996) Arthroscopy for acute knee haemarthrosis in road traffic accident victims. Injury 27:341–343CrossRefPubMed Lu KH, Hsiao YM, Lin ZI (1996) Arthroscopy for acute knee haemarthrosis in road traffic accident victims. Injury 27:341–343CrossRefPubMed
14.
go back to reference Kleiner DE, Stetler-Stevenson WG (1994) Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem 218:325–329CrossRefPubMed Kleiner DE, Stetler-Stevenson WG (1994) Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem 218:325–329CrossRefPubMed
15.
go back to reference Chou FP, Chu SC, Cheng MC et al. (2002) Effect of hemodialysis on the plasma level of type IV collagenases and their inhibitors. Clin Biochem 35:383–388CrossRefPubMed Chou FP, Chu SC, Cheng MC et al. (2002) Effect of hemodialysis on the plasma level of type IV collagenases and their inhibitors. Clin Biochem 35:383–388CrossRefPubMed
16.
go back to reference Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal Biochem 162:156–159 Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal Biochem 162:156–159
17.
go back to reference Kuo WH, Yang SF, Chu SC, Lu SO, Chou FP, Hsieh YS (2003) Differential inductions of MMP-2 and MMP-9 in host tissue during the growth of ascitic sarcoma 180 cells in mice. Cancer Lett 189:103–112CrossRefPubMed Kuo WH, Yang SF, Chu SC, Lu SO, Chou FP, Hsieh YS (2003) Differential inductions of MMP-2 and MMP-9 in host tissue during the growth of ascitic sarcoma 180 cells in mice. Cancer Lett 189:103–112CrossRefPubMed
18.
go back to reference Okada Y, Shinmei M, Tanaka O (1992) Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest 66:680–690PubMed Okada Y, Shinmei M, Tanaka O (1992) Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest 66:680–690PubMed
19.
go back to reference Fosang AJ, Last K, Knauper V, Murphy G, Neame PJ (1996) Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett 380:17–20CrossRefPubMed Fosang AJ, Last K, Knauper V, Murphy G, Neame PJ (1996) Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett 380:17–20CrossRefPubMed
20.
go back to reference Seltzer JL, Adams SA, Grant GA, Eisen AZ (1981) Purification and properities of a gelatin-specific neutral protease from human skin. J Biol Chem 256:4662–4668PubMed Seltzer JL, Adams SA, Grant GA, Eisen AZ (1981) Purification and properities of a gelatin-specific neutral protease from human skin. J Biol Chem 256:4662–4668PubMed
21.
go back to reference Murphy G, Reynolds JJ, Bretz U, Baggiolini M (1982) Partial purification of collagenase and gelatinase from human polymorphonuclear leukocytes: analysis of their actions on soluble and insoluble collagens. Biochem J 203:209–221PubMed Murphy G, Reynolds JJ, Bretz U, Baggiolini M (1982) Partial purification of collagenase and gelatinase from human polymorphonuclear leukocytes: analysis of their actions on soluble and insoluble collagens. Biochem J 203:209–221PubMed
22.
go back to reference Okada Y, Mordomi T, Enghild JJ et al. (1990) Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precusor and enzymatic properities. Eur J Biochem 194:721–730PubMed Okada Y, Mordomi T, Enghild JJ et al. (1990) Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precusor and enzymatic properities. Eur J Biochem 194:721–730PubMed
23.
go back to reference Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI, Welgus HG (1991) Human 92- and 72-kilodalton type IV collagenases and elastases. J Biol Chem 266:7870–7875PubMed Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI, Welgus HG (1991) Human 92- and 72-kilodalton type IV collagenases and elastases. J Biol Chem 266:7870–7875PubMed
24.
go back to reference Nguyen Q, Murphy G, Hughes CE, Mort JS, Roughley PJ (1993) Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein. Biochem J 295:595–598PubMed Nguyen Q, Murphy G, Hughes CE, Mort JS, Roughley PJ (1993) Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein. Biochem J 295:595–598PubMed
25.
go back to reference Hembry RM, Bagga MR, Reynolds JJ, Hamblen DL (1995) Immunolocalization studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovial from patients with osteo- and rheumatoid arthritis. Ann Rheum Dis 54:25–32PubMed Hembry RM, Bagga MR, Reynolds JJ, Hamblen DL (1995) Immunolocalization studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovial from patients with osteo- and rheumatoid arthritis. Ann Rheum Dis 54:25–32PubMed
26.
go back to reference Nagase H, Okada Y (1996) Proteinases and matrix degradation. In: Kelly WN, Harris ED Jr, Ruddy S, Sledge CB (eds) The textbook of rheumatology, 5th edn. WB Saunders, Philadelphia, pp 323–341 Nagase H, Okada Y (1996) Proteinases and matrix degradation. In: Kelly WN, Harris ED Jr, Ruddy S, Sledge CB (eds) The textbook of rheumatology, 5th edn. WB Saunders, Philadelphia, pp 323–341
27.
go back to reference Ahrens D, koch AE, Pope RM, Stein-Picarella M, Niedbala MJ (1996) Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. Arthritis Rheum 39:1576–1587PubMed Ahrens D, koch AE, Pope RM, Stein-Picarella M, Niedbala MJ (1996) Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. Arthritis Rheum 39:1576–1587PubMed
28.
go back to reference Grillet B, Dequeker J, Paemen L, Damme BV, Opdenakker G (1997) Gelatinase B in synovitis: immunolocalization with a monoclonical antibody. Br J Rheumatol 36:744–747CrossRefPubMed Grillet B, Dequeker J, Paemen L, Damme BV, Opdenakker G (1997) Gelatinase B in synovitis: immunolocalization with a monoclonical antibody. Br J Rheumatol 36:744–747CrossRefPubMed
29.
go back to reference Zhang Y, McCluskey K, Fujii K, Wahl LM (1998) Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte- macrophage CSF, and IL-1 beta through prostaglandin-dependent and independent mechanism. J Immunol 161:3071–3076PubMed Zhang Y, McCluskey K, Fujii K, Wahl LM (1998) Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte- macrophage CSF, and IL-1 beta through prostaglandin-dependent and independent mechanism. J Immunol 161:3071–3076PubMed
30.
go back to reference Pugin J, Widmer MC, Kossodo S, Liang CM, Preas HL II, Suffredini AF (1999) Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators. Am J Respir Cell Mol Biol 20:458–464PubMed Pugin J, Widmer MC, Kossodo S, Liang CM, Preas HL II, Suffredini AF (1999) Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators. Am J Respir Cell Mol Biol 20:458–464PubMed
31.
go back to reference Matrisian LM (1990) Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6:121–125PubMed Matrisian LM (1990) Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6:121–125PubMed
32.
go back to reference Fini ME, Cook JR, Mohan R, Brinckerhoff CE (1998) Regulation of matrix metalloproteinase gene expression. In: Parks WC, Mecham RP (eds) Matrix metalloproteinases. Academic Press, San Diego, pp 300–356 Fini ME, Cook JR, Mohan R, Brinckerhoff CE (1998) Regulation of matrix metalloproteinase gene expression. In: Parks WC, Mecham RP (eds) Matrix metalloproteinases. Academic Press, San Diego, pp 300–356
Metadata
Title
The significance of altered gelatinase expression in the synovium of patient with arthritic effusions
Authors
Ko-Hsiu Lu
Shun-Fa Yang
Shu-Chen Chu
Pei-Ni Chen
Ming-Chih Chou
Tang-Yan Hsiao
Yih-Shou Hsieh
Publication date
01-02-2004
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 1/2004
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-003-0774-6

Other articles of this Issue 1/2004

Clinical Rheumatology 1/2004 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.